Results 181 to 190 of about 12,954,964 (236)

Absence of Interaction Between 5α-Reductase Inhibitors and Glucocorticoids on Incidence of Myocardial Infarction in People With Type 2 Diabetes. [PDF]

Diabetes Obes Metab
Tu H, Ju C, McGurnaghan SJ, Blackbourn LAK, Scottish Diabetes Research Network Epidemiology Group, Pearson ER, Wei L, Andrew R.   +7 more
europepmc   +1 more source

Curcumin versus placebo in benign prostatic hyperplasia: a systematic review and meta-analysis. [PDF]

Eur J Clin Pharmacol
Santana DS, Porto BC, Cardoso RB, Lopes GMM, Gimenez LGS, Passerotti CC, Maia R, Almeida FG, da Silva Sardenberg RA, da Cruz JAS.   +9 more
europepmc   +1 more source

Ammonia fumigation combined with nitrogen inhibitor reduces root-knot nematode populations and N₂O emission but not bacterial alpha diversity. [PDF]

Front Microbiol
Shi F, Fu J, Li P, Li X, Liu J, Zhu Y.
europepmc   +1 more source

Targeting Aromatase and 5-α-Reductase to Limit Dysfunctional Adipogenesis in Multiple Symmetric Lipomatosis. [PDF]

Biomedicines
Milan G, Compagnin C, Zucal I, Perale G, Bettini S, Pilatone A, De Monti M, Harder Y, Parodi C, Schmauss D, Vindigni V, Bassetto F, Felthaus O, Oliinyk D, Prantl L, Busetto L.   +15 more
europepmc   +1 more source

Androgen-Modulating Drugs and Severe Complications After ST-Elevation Myocardial Infarction.

JAMA Netw Open
Colldén H, Lundberg CE, Björck L, Redfors B, Rosengren A, Tivesten Å.   +5 more
europepmc   +1 more source

5-Alpha-Reductase Inhibitors and Combination Therapy

Urologic Clinics of North America, 2016
By inhibiting the conversion from testosterone to dihydrotestosterone 5-Alpha reductase inhibitors (5ARIs) are able to hinder prostatic growth, shrink prostate volumes, and improve BPH-related LUTS. 5ARIs are particularly beneficial for patients with larger prostates (>30-40ml).
Marc Philipp Schneider, Claudius Füllhase   +1 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

The risk of dementia with the use of 5 alpha reductase inhibitors

Journal of the Neurological Sciences, 2017
There has been considerable interest in the interplay between testosterone and cognition. Dihydrotestosterone (DHT), which has been correlated with cognitive function, is significantly reduced with the use of 5 alpha reductase inhibitors (5ARI) for prostatic enlargement.
Blayne Welk, Sarah Anne Morrow, Michael Ordon   +2 more
exaly   +3 more sources

Discovery of Natural Steroid 5 Alpha-Reductase Inhibitors

Assay and Drug Development Technologies, 2019
Human steroid 5 alpha-reductases (S5αRs) and NADPH irreversibly reduce testosterone to the more potent dihydrotestosterone (DHT). S5αR inhibitors are useful treatments for DHT-dependent diseases, including benign prostatic hyperplasia, androgenic alopecia and hair growth, and acne.
C Norman Scholfield, Kornkanok Ingkaninan, Jukkarin Srivilai   +2 more
exaly   +3 more sources

5 Alpha-reductase inhibitors: whatʼs new?

Current Opinion in Urology, 2003
Medical therapy is now the first-line treatment for most men with symptomatic benign prostatic hyperplasia. This review aims to highlight the recent contributions to our understanding of 5 alpha-reductase inhibitor usage.For the last decade, finasteride has been the only available 5 alpha-reductase inhibitor, acting upon the type 2 isoenzyme of 5-alpha
Charlotte L, Foley, Roger S, Kirby
openaire   +2 more sources